Genetic Susceptibility to Kidney Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

6 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-07-31

Study Completion Date

2013-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will further the understanding of the genetic events leading to the development of RCC.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer

NCT00908739

Kidney Cancer

WITHDRAWN

A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer

NCT00918008

Bladder Cancer

TERMINATED

Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer

NCT00899860

Kidney Cancer

TERMINATED

Genetic Investigation of Cancer Predisposition

NCT04620278

Genetic Predisposition Cancer

NOT_YET_RECRUITING

Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer

NCT00050752

Renal Tumor Histology Cutaneous Leiomyoma Kidney Cancer

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will further the understanding of the genetic events leading to the development of RCC; explore the genetic basis for genetic instability and how it affects cancer risk; and eventually provide a means of identifying a subgroup of individuals who are most likely to develop RCC. Such individuals may then be targeted for intervention programs such as chemoprevention or dietary modification.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Cell Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy

Healthy adults, of any ethnicity, or sex, and with no previous history of cancer, except for non-melanoma skin cancer

No interventions assigned to this group

RCC

Adult patients with newly diagnosed (diagnosed within the year of enrollment) renal carcinoma (RCC) any ethnicity, or sex, who have not received prior chemotherapy or radiotherapy.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients of any ethnicity or sex, who have a been diagnosed with possible Renal Cell Carcinoma within the past year.

Exclusion Criteria

* Must not have received chemotherapy, biological therapy or radiation therapy in the 6 months preceding enrollment will
* Must not have had RCC, or metastatic RCC,
* Must not have had a renal transplantation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No